Month: March 2020

Selskabsmeddelelse18. marts 2020Meddelelse nr. 4/2020Bestyrelsen i Nilfisk Holding A/S har truffet beslutning om at udskyde selskabets ordinære generalforsamling, der skulle være afholdt den 19. marts 2020.Beslutningen er truffet af hensyn til aktionærernes og medarbejdernes sikkerhed, og som følge af de danske myndigheders seneste COVID-19 retningslinjer for afholdelse af arrangementer, der blev kommunikeret den 17. marts.Grundet den aktuelle usikkerhed omkring forløbet af COVID-19 pandemien, er der endnu ikke fastlagt en ny dato for afholdelse af generalforsamlingen. Det forventes dog at afholde generalforsamlingen inden udgangen af april med forbehold for lovændringer. Når der foreligger en ny dato, udsendes indkaldelse med agenda.KontaktInvestor RelationsJens Bak-HolderHead of Investor RelationsT: +45 2128 5832Media RelationsLouise...

Company announcementMarch 18, 2020Announcement No. 4/2020The Board of Directors in Nilfisk Holding A/S has decided to postpone the company’s Annual General Meeting scheduled for March 19, 2020.The decision is made out of respect for shareholder and employee safety, and due to the recent COVID-19 guidelines regarding events communicated by the Danish authorities on March 17.Given the current uncertainty related to the course of the COVID-19 pandemic a new date for the Annual General Meeting is still to be determined. However, the Annual General Meeting will expectedly be held before end of April unless new regulatory requirements are issued. Once a date is set, a notice with agenda will be published.ContactInvestor RelationsJens Bak-HolderHead of Investor RelationsT: +45 2128 5832Media RelationsLouise Refsgaard KlingeGlobal Media RelationsT:...

TRAINERS’ HOUSE OYJ, PÖRSSITIEDOTE, 18.3.2020 KLO 8:50

Communiqué de presseChiffre d’affaires consolidé à 861,8 millions d’euros, en hausse de 7,9% à cours de change variables (+4,6% à cours de change constants)Résultat d’exploitation de 59,8 millions d’euros (+21,3%)Résultat net à 61,4 millions d’eurosRésultat net – part du groupe à 43,2 millions d’eurosDividende de 25 centimes par action* Variations calculées sur la base des montants en K€Le Conseil d’administration de VIEL & Cie s’est réuni le 17 mars 2020 pour examiner et arrêter les comptes de l’exercice 2019. Ces comptes annuels et consolidés sont en cours d’audit par le collège des Commissaires aux Comptes de la Société.Les états financiers dans leur intégralité seront inclus dans le rapport financier annuel de la Société.Aperçu des activitésL’activité d’intermédiation professionnelle du Groupe au travers de Compagnie Financière...

Grant of US patent covering the use of PTH containing matrices for spinal fusionGrant of US patent covering osteoinductive materials made by certain methodsFurther strengthens Kuros’s position as a leader in the field of orthobiologicsSCHLIEREN (ZURICH), Switzerland, March 18, 2020 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced that its subsidiary, Kuros Biosurgery AG, has been granted the US patent, US 10’589’001, entitled ‘Pharmaceutical formulation for use in spinal fusion’. This patent covers the use of parathyroid hormone (PTH) containing matrices for spinal fusion. The granting of this patent strengthens Kuros proprietary position on the use of PTH containing matrices in spinal fusion, the primary indication of Kuros’ Fibrin-PTH development program.Kuros’s intellectual property portfolio in orthobiologics,...

Paris, March 18, 2020 – The Fiscal 2020 1st half landing to be published on April 9, 2020 is expected to be in line with internal forecasts and aligned with the Fiscal 2020 annual guidance.The COVID-19 pandemic started to be a concern in the second half of January for our business in China, leading to a rapid deterioration worldwide in February, moving from region to region and generating more and more government precautionary measures to limit the spread of the virus.Sodexo is coordinating globally, regionally and locally to manage its business continuity and pandemic plans to support and protect its employees and consumers across all of its geographies. The health and safety of Sodexo employees and consumers is our utmost priority. Sodexo has reinforced the existing rules for food safety, personal hygiene and infection control.As the...

Paris, 18 mars 2020 – L’atterrissage du 1er semestre de l’exercice 2019-2020, qui sera publié le 9 avril 2020, devrait être conforme aux prévisions internes et aligné sur les objectifs annuels de l’exercice.La pandémie de COVID-19 a commencé à produire des effets sur notre activité en Chine à partir de la deuxième quinzaine de janvier, avant de s’accentuer rapidement dans le monde entier en février, le virus se propageant d’une région à l’autre et générant de plus en plus de mesures gouvernementales de sécurité pour limiter sa propagation.Sodexo se coordonne à l’échelle mondiale, régionale et locale pour assurer la continuité de ses activités et appliquer ses plans en cas de pandémie afin de soutenir et de protéger ses employés et ses consommateurs dans l’ensemble de ses géographies.La santé et la sécurité...

Geneva, Switzerland, March 18, 2020 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that due to the impact of the COVID-19 coronavirus pandemic, the start of the registrational efficacy and safety study (Study 301) of dipraglurant to treat levodopa induced dyskinesia (PD-LID) in patients with Parkinson’s disease has been postponed. In addition, the company will delay reporting its full year 2019 audited financial results and associated investor conference call till April 8, 2020.Addex has taken the decision to postpone the start of the dipraglurant study due to the fact that the intended patient population is among the highest risk category for severe illness and death associated with COVID-19. Public health...

 The Board of Directors has decided to postpone the 25th Annual General Meeting planned for March 30, 2020 

Reducing 2020 revenue and EBIT expectationsHelsinki, 18 March 2020 – Ferratum Oyj (ISIN: FI4000106299, WKN: A1W9NS) (“Ferratum” or the “Group”) reduces 2020 revenue and EBIT expectations.In 2020, the Board of Ferratum Oyj expects the Covid-19 pandemic to have a material impact on the Groups performance. Revenue and EBIT are expected to materially decrease compared to 2019.Taking into consideration the current macro-economic uncertainty, impairment levels are expected to increase during 2020. An expectation of deteriorating economic indicators would increase impairments driven by the implemented statistical risk reserving model. In addition, the Board expects continued high volatility in FX rates as a consequence of the Covid-19 outbreak and the oil market turmoil which might have a negative impact on net profitability in 2020.About Ferratum...